rchi - FACEIT level 10, 2,569 ELO

United Kingdom
On FACEIT since 2015 212 matches tracked 52 matches in 30 days
ELO ▼ 118
2,569
30-day peak: 2,867
Rank EU
#41,387
United Kingdom #719 in United Kingdom
Last updated:

rchi at a glance

Level 10 2,569 ELO best map Nuke (63%)
2,500-2,749 ELO

Last 20 matches compared with 2,994 players in this group: K/R above average, ADR and win rate below average.

RatingCalculated with the HLTV Rating 1.0 formula from kills, deaths and multi-kills per round. 1.00 is an average match.
better than 70%
1.11
SpreadHow much the rating swings from match to match. The smaller, the more consistent. ±0.30 ConsistencyShare of matches with a rating of 0.90 or higher. 75%
K/R
0.76
better than 56% of players
2,500-2,749 ELO avg: 0.75
Last 12 months
ADR
78.2
better than 35% of players
2,500-2,749 ELO avg: 81.1
Last 12 months
Win rate
40%
better than 13% of players
2,500-2,749 ELO avg: 50%
Last 12 months

Facts

590 ELO Next goal That is 10 to 19 wins.
3 W · 0 L Best day +90 ELO · Sep 29, 2026
Ancient Favorite map 58 of 207 matches
Nuke 63% Map pool tip weakest: Cache 33%
3 knife kills Rare kills last 90 days
13:00-23:00 Playing times On Sundays
On Sundays Best time 59% win rate vs. 50%
FormMapsTiming

590 ELO away from the recorded peak (3,159). That is 10 to 19 wins. 3:0 on Sep 29, 2026 (+90 ELO, last 90 days). Most played: Ancient (58 of 207 matches). Strongest map: Nuke (63% win rate, 30 matches). Weakest: Cache (33%, 15 matches). 3 knife kills (last 90 days). Plays most on Sundays between 13:00 and 23:00 (based on 207 matches). Best results on Sundays: 59% win rate vs. 50% overall (44 matches).

About rchi

rchi plays CS2 on FACEIT level 10 with 2,569 ELO. The stats cover 207 matches. The strongest map is Nuke with a 63% win rate in 30 matches. Most played: Ancient with 58 matches and a 52% win rate. Biggest strength: Headshot rate at 66%, better than 99% of level 10 · 2,500-2,749 ELO players. Last 20 matches: 8 wins, 12 losses, -149 ELO. rchi does best on Sundays: 59% win rate in 44 matches.